
|Articles|October 1, 2000
Supplements and Featured Publications
- Scientific, Clinical, and Economic Rationale for Combination Therapy in Managing Asthma
- Volume 6
- Issue 17 Suppl
Selected Abstracts
Advertisement
Articles in this issue
about 25 years ago
Participating Facultyabout 25 years ago
Introductionabout 25 years ago
Current Asthma Management: The Performance Gap and Economic Consequencesabout 25 years ago
Economic Analysis of Asthma Practicesabout 25 years ago
Managing Asthma in Adultsabout 25 years ago
Continuing Medical Education QuizNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates
4
Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD
5















































